Suining Central Hospital

Running trials

• Recruiting

  A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07795346· Phase 3· Source

• Recruiting

  Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer

  NCT07855965· Phase 2· Source

• Recruiting

  A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

  NCT07724366· Phase 3· Source

• Recruiting

  Phase II Study of RC1416 Injection in COPD

  NCT07402551· Phase 2· Source

• Recruiting

  JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.

  NCT07284134· Phase 3· Source

• Active, not recruiting

  A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

  NCT07220538· Phase 4· Source

• Recruiting

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  NCT07028853· Phase 3· Source

• Not yet recruiting

  Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

  NCT07147946· Phase 3· Source

• Recruiting

  TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

  NCT07047365· Phase 3· Source

• Recruiting

  TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

  NCT06829784· Phase 3· Source

• Active, not recruiting

  A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT06789289· Phase 2· Source

• Recruiting

  A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

  NCT07673029· Phase 3· Source

• Recruiting

  Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC

  NCT07748325· Phase 2· Source

• Active, not recruiting

  A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT06707883· Phase 2· Source

• Active, not recruiting

  Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

  NCT06360458· Phase 3· Source

• Active, not recruiting

  PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

  NCT06419621· Phase 3· Source

• Recruiting

  Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

  NCT06315231· Phase 2· Source

• Active, not recruiting

  A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

  NCT06984588· Phase 2/3· Source

• Recruiting

  JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects

  NCT06079983· Phase 3· Source

• Active, not recruiting

  Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

  NCT06577792· Source

• Active, not recruiting

  To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer

  NCT05365178· Phase 3· Source

• Active, not recruiting

  PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

  NCT05180734· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer3 recruiting
• COPD2 recruiting
• Gastric and esophageal cancer2 recruiting
• Lung cancer2 recruiting
• Asthma1 recruiting
• Psoriasis1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis

  NCT07549269· Source

• Completed

  Survival Prediction After Neoadjuvant Chemoimmunotherapy and Esophagectomy for Esophageal Squamous Cell Carcinoma

  NCT07488624· Source

• Completed

  A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

  NCT07357831· Phase 3· Source

• Completed

  A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

  NCT07252908· Phase 2· Source

• Completed

  HPP737 in Adult Patients With Plaque Psoriasis

  NCT07712731· Phase 3· Source

• Completed

  A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

  NCT06738979· Phase 3· Source

• Completed

  To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

  NCT06552520· Phase 3· Source

• Completed

  A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT06527144· Phase 2· Source

• Completed

  A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

  NCT06115902· Phase 1· Source

• Completed

  Head Position After Endovascular Therapy

  NCT06115707· Source

• Completed

  A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

  NCT05975268· Phase 3· Source

• Completed

  A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

  NCT05987371· Phase 2· Source

• Completed

  A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis

  NCT05770609· Phase 2· Source

• Completed

  HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

  NCT07712705· Phase 3· Source

• Completed

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· Phase 3· Source

• Completed

  Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

  NCT05631847· Source

• Completed

  Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

  NCT05593575· Phase 2· Source

• Completed

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903

  NCT06846099· Phase 1· Source

• Completed

  Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

  NCT05590793· Phase 3· Source

• Completed

  ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)

  NCT05507645· Phase 3· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

  NCT05352516· Phase 3· Source

• Completed

  To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil

  NCT06500689· Phase 3· Source

• Completed

  A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

  NCT04540211· Phase 3· Source